Dipesh Budhathoki received his Bachelor’s degree in Pharmacy from the Institute of Medicine, Nepal in 2014. He is currently a Master’s student in Pharmaceutical Science at the ISU Meridian Health Science Center. His concentration is Medicinal Chemistry, and is currently working under the supervision of Dr. Kirk Hevener. His research interests comprise applications of computational techniques in molecular modeling and rational drug design, including molecular simulation, docking, and virtual screening
Jesse A. Jones
Jesse A. Jones received his B.S. from Boise State University in 2008. He then started work toward a Pharm.D. in Pocatello, ID at Idaho State University (ISU), which he completed in Meridian, ID at the ISU Meridian Health Science Center in 2012. He is a Ph.D. student in Pharmaceutical Sciences with a concentration in Drug Discovery at the ISU Meridian Health Science Center under Dr. Kirk E. Hevener, where he has been for three years. His research interests include the rational discovery and design of antimicrobial agents, including the use of molecular biochemistry and structural biology.
Aoxiang Tao AKA “Oliver”
Aoxiang Tao AKA “Oliver” received his B.S. in Pharmacy from Xiangtan University in 2012. He has previously been employed as a workshop operator, quality assurance specialist, quality auditor, and supplier administrator in the pharmaceutical industry in China. He is currently a Ph.D. student in Pharmaceutical Sciences with a concentration in Medicinal Chemistry at the ISU Meridian Health Science Center under Dr. Dong Xu. His research interests include PPI (protein-protein interaction) prediction, drug repurposing and novel drug design.
Janet Bobango is a Ph.D. student in the Biomedical and Pharmaceutical Sciences department at the ISU Meridian Health Science Center. A member of Dr. Todd Talley’s laboratory, Janet’s concentration is on drug discovery for nicotinic acetylcholine receptors and related ligand gated ion channels. Her research interests include molecular pharmacology, structural biology, and structure-based drug design.